Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Spondylitis, Ankylosing 1Somatoform Disorders 1Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Breast Neoplasms 1Breast Neoplasm Female 1Bone Neoplasms 1

Interventions

Acupuncture Therapy 10Exercise 7Cryotherapy 6Paclitaxel 5Glutamine 5Surveys and Questionnaires 3Duloxetine Hydrochloride 3Dexamethasone 3Bortezomib 3Acetylcysteine 3pembrolizumab 2enfortumab vedotin 2Thioctic Acid 2Tablets 2Sodium Chloride 2Saline Solution 2Physical Therapy Modalities 2Low-Level Light Therapy 2Lenalidomide 2Fish Oils 2Fatty Acids, Omega-3 2ziconotide 1sagopilone 1nicotinamide-beta-riboside 1nabilone 1glutamic acid diethyl ester 1eribulin 1allantoicase 1Yoga 1XELOX 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peripheral Nervous System Diseases × Etoricoxib × Clear all
NCT04565600 2022-02-14

Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib

Guangdong Provincial People's Hospital

Phase 2 Completed
144 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases, Somatoform Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡